AMADORI, DAVIDE
AMADORI, DAVIDE
Circulating androgen receptor (AR) gene amplification and resistance to 177Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of a phase II clinical trial
2019 De Giorgi, U; Severi, S; Sarnelli, A; Sansovini, M; Monti, M; Gurioli, G; Nicolini, S; Scarpi, E; Casadei, C; Conteduca, V; Matteucci, F; Di Iorio, V; Amadori, D; Paganelli, G
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population?
2018 Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N.; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G.
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
2018 Conteduca V.; Gurioli G.; Rossi L.; Scarpi E.; Lolli C.; Schepisi G.; Farolfi A.; De Lisi D.; Galla V.; Burgio S.L.; Menna C.; Amadori A.; Losi L.; Amadori D.; Costi M.P.; De Giorgi U.
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy
2016 Gennari A.; Amadori D.; Scarpi E.; Farolfi A.; Paradiso A.; Mangia A.; Biglia N.; Gianni L.; Tienghi A.; Rocca A.; Maltoni R.; Antonucci G.; Bruzzi P.; Nanni O.
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer
2015 Rocca A.; Farolfi A.; Maltoni R.; Carretta E.; Melegari E.; Ferrario C.; Cecconetto L.; Sarti S.; Schirone A.; Fedeli A.; Andreis D.; Pietri E.; Ibrahim T.; Montalto E.; Amadori D.
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015 Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bravaccini S.; Serra P.; Farolfi A.; Amadori D.
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer
2015 Farolfi A.; Scarpi E.; Rocca A.; Mangia A.; Biglia N.; Gianni L.; Tienghi A.; Valerio M.R.; Gasparini G.; Amaducci L.; Faedi M.; Baldini E.; Rubagotti A.; Maltoni R.; Paradiso A.; Amadori D.
Clinical and genetic factors related to cancer-induced bone pain and bone pain relief
2014 Scarpi E.; Calistri D.; Klepstad P.; Kaasa S.; Skorpen F.; Habberstad R.; Nanni O.; Amadori D.; Maltoni M.
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer
2014 Rocca A.; Farolfi A.; Bravaccini S.; Schirone A.; Amadori D.
Erratum: Managing chronic pain: Results from an open-label study using MC5-A Calmare® device (Support Care Cancer (2012) 20 (405-412) DOI 10.1007/s00520-011-1128-6)
2013 Ricci M.; Pirotti S.; Scarpi E.; Burgio M.; Maltoni M.; Sansoni E.; Amadori D.
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact
2013 Ibrahim T.; Farolfi A.; Scarpi E.; Mercatali L.; Medri L.; Ricci M.; Nanni O.; Serra L.; Amadori D.
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors
2013 Farolfi A.; Melegari E.; Aquilina M.; Scarpi E.; Ibrahim T.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Ferrario C.; Fedeli A.; Faedi M.; Nanni O.; Frassineti G.L.; Amadori D.; Rocca A.
Ipilimumab in advanced melanoma: Reports of long-lasting responses
2012 Farolfi A.; Ridolfi L.; Guidoboni M.; Nicoletti S.V.L.; Piciucchi S.; Valmorri L.; Costantini M.; Scarpi E.; Amadori D.; Ridolfi R.
Palliative sedation in end-of-life care and survival: A systematic review
2012 Maltoni M.; Scarpi E.; Rosati M.; Derni S.; Fabbri L.; Martini F.; Amadori D.; Nanni O.
Prospective comparison of prognostic scores in palliative care cancer populations
2012 Maltoni M.; Scarpi E.; Pittureri C.; Martini F.; Montanari L.; Amaducci E.; Derni S.; Fabbri L.; Rosati M.; Amadori D.; Nanni O.
Prospective observational Italian study on palliative sedation in two hospice settings: Differences in casemixes and clinical care
2012 Maltoni M.; Miccinesi G.; Morino P.; Scarpi E.; Bulli F.; Martini F.; Canzani F.; Dall'Agata M.; Paci E.; Amadori D.
Reply to E. Schildmann et al
2012 Maltoni M.; Scarpi E.; Rosati M.; Derni S.; Fabbri L.; Martini F.; Amadori D.; Nanni O.
Evaluation of the cost of home care for terminally ill cancer patients
1997 Maltoni, M.; Travaglini, C.; Santi, M.; Nanni, O.; Scarpi, E.; Benvenuti, S.; Albertazzi, L.; Amaducci, L.; Derni, S.; Fabbri, L.; Masi, A.; Montanari, L.; Pasini, G.; Polselli, A.; Tonelli, U.; Turci, P.; Amadori, D.
Primary lymphoma of the central nervous system
1991 Amadori M.; Maltoni M.; Ravaioli A.; Rosti G.; Pasquini E.; Leoni M.; Amadori D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Circulating androgen receptor (AR) gene amplification and resistance to 177Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of a phase II clinical trial | De Giorgi, U; Severi, S; Sarnelli, A; Sansovini, M; Monti, M; Gurioli, G; Nicolini, S; Scarpi, E;... Casadei, C; Conteduca, V; Matteucci, F; Di Iorio, V; Amadori, D; Paganelli, G | 2019-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? | Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N....; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G. | 2018-01-01 | FRONTIERS IN ENDOCRINOLOGY | - | 1.01 Articolo in rivista | - |
| Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer | Conteduca V.; Gurioli G.; Rossi L.; Scarpi E.; Lolli C.; Schepisi G.; Farolfi A.; De Lisi D.; Gal...la V.; Burgio S.L.; Menna C.; Amadori A.; Losi L.; Amadori D.; Costi M.P.; De Giorgi U. | 2018-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | - |
| Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy | Gennari A.; Amadori D.; Scarpi E.; Farolfi A.; Paradiso A.; Mangia A.; Biglia N.; Gianni L.; Tien...ghi A.; Rocca A.; Maltoni R.; Antonucci G.; Bruzzi P.; Nanni O. | 2016-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer | Rocca A.; Farolfi A.; Maltoni R.; Carretta E.; Melegari E.; Ferrario C.; Cecconetto L.; Sarti S.;... Schirone A.; Fedeli A.; Andreis D.; Pietri E.; Ibrahim T.; Montalto E.; Amadori D. | 2015-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bra...vaccini S.; Serra P.; Farolfi A.; Amadori D. | 2015-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.03 Recensione in rivista | - |
| Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer | Farolfi A.; Scarpi E.; Rocca A.; Mangia A.; Biglia N.; Gianni L.; Tienghi A.; Valerio M.R.; Gaspa...rini G.; Amaducci L.; Faedi M.; Baldini E.; Rubagotti A.; Maltoni R.; Paradiso A.; Amadori D. | 2015-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Clinical and genetic factors related to cancer-induced bone pain and bone pain relief | Scarpi E.; Calistri D.; Klepstad P.; Kaasa S.; Skorpen F.; Habberstad R.; Nanni O.; Amadori D.; M...altoni M. | 2014-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer | Rocca A.; Farolfi A.; Bravaccini S.; Schirone A.; Amadori D. | 2014-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.03 Recensione in rivista | - |
| Erratum: Managing chronic pain: Results from an open-label study using MC5-A Calmare® device (Support Care Cancer (2012) 20 (405-412) DOI 10.1007/s00520-011-1128-6) | Ricci M.; Pirotti S.; Scarpi E.; Burgio M.; Maltoni M.; Sansoni E.; Amadori D. | 2013-01-01 | SUPPORTIVE CARE IN CANCER | - | 1.01 Articolo in rivista | - |
| Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact | Ibrahim T.; Farolfi A.; Scarpi E.; Mercatali L.; Medri L.; Ricci M.; Nanni O.; Serra L.; Amadori D. | 2013-01-01 | ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors | Farolfi A.; Melegari E.; Aquilina M.; Scarpi E.; Ibrahim T.; Maltoni R.; Sarti S.; Cecconetto L.;... Pietri E.; Ferrario C.; Fedeli A.; Faedi M.; Nanni O.; Frassineti G.L.; Amadori D.; Rocca A. | 2013-01-01 | HEART | - | 1.01 Articolo in rivista | - |
| Ipilimumab in advanced melanoma: Reports of long-lasting responses | Farolfi A.; Ridolfi L.; Guidoboni M.; Nicoletti S.V.L.; Piciucchi S.; Valmorri L.; Costantini M.;... Scarpi E.; Amadori D.; Ridolfi R. | 2012-01-01 | MELANOMA RESEARCH | - | 1.01 Articolo in rivista | - |
| Palliative sedation in end-of-life care and survival: A systematic review | Maltoni M.; Scarpi E.; Rosati M.; Derni S.; Fabbri L.; Martini F.; Amadori D.; Nanni O. | 2012-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Prospective comparison of prognostic scores in palliative care cancer populations | Maltoni M.; Scarpi E.; Pittureri C.; Martini F.; Montanari L.; Amaducci E.; Derni S.; Fabbri L.; ...Rosati M.; Amadori D.; Nanni O. | 2012-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Prospective observational Italian study on palliative sedation in two hospice settings: Differences in casemixes and clinical care | Maltoni M.; Miccinesi G.; Morino P.; Scarpi E.; Bulli F.; Martini F.; Canzani F.; Dall'Agata M.; ...Paci E.; Amadori D. | 2012-01-01 | SUPPORTIVE CARE IN CANCER | - | 1.01 Articolo in rivista | - |
| Reply to E. Schildmann et al | Maltoni M.; Scarpi E.; Rosati M.; Derni S.; Fabbri L.; Martini F.; Amadori D.; Nanni O. | 2012-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Evaluation of the cost of home care for terminally ill cancer patients | Maltoni, M.; Travaglini, C.; Santi, M.; Nanni, O.; Scarpi, E.; Benvenuti, S.; Albertazzi, L.; Ama...ducci, L.; Derni, S.; Fabbri, L.; Masi, A.; Montanari, L.; Pasini, G.; Polselli, A.; Tonelli, U.; Turci, P.; Amadori, D. | 1997-01-01 | SUPPORTIVE CARE IN CANCER | - | 1.01 Articolo in rivista | - |
| Primary lymphoma of the central nervous system | Amadori M.; Maltoni M.; Ravaioli A.; Rosti G.; Pasquini E.; Leoni M.; Amadori D. | 1991-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |